Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

CPAP Could Ease Depression in OSA

Patients with obstructive sleep apnea (OSA) are at increased risk for depression, but continuous positive airway pressure (CPAP) therapy may ease their depression symptoms, a new study suggests.

Non-Adherence to Asthma a Growing Problem

An analysis published in the Journal of Clinical Pharmacy and Therapeutics of asthma medication adherence showed poor coverage across a six-month period.

New Recs for IPF Rx Therapy

Updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF) by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association have been published.

Cloud9 Anti-Snoring System Approved

The FDA has cleared its Cloud9 Anti-Snoring System to reduce or eliminate asymptomatic ("simple") snoring in adults.

When Should LABA Therapy Be Stopped?

An article highlights studies on cessation of LABA compared to continued use of LABA/ICS for adults with well-controlled asthma to determine whether stopping LABA treatment has an impact on asthma control, exacerbations, and other serious adverse events.

Soy Supplements for Uncontrolled Asthma

A new study has found that supplementation with soy isoflavone did not improve lung function or critical outcomes in patients with poor asthma control, despite previous research suggesting that it may be an effective treatment.

Regular Aspirin May Slow Emphysema Progression

Regular aspirin use is associated with a slower progression of early emphysema on computed tomography (CT) scans over the course of 10 years.

Breo Ellipta Inhaler Gains Expanded Indication

GlaxoSmithKline and Theravance announced that the Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged ≥18 years.


COPD Drug Recalled Due to Counter Display Error

AstraZeneca announced a voluntary recall of certain lots of Tudorza Pressair (aclidinium bromide) where the counter ring for some devices is not initially set to "60" in the viewing window.

Does Having a Respiratory Condition Lower the Risk of Glioma?

Patients with respiratory allergies, asthma, and eczema may be less likely to develop a glioma, according to a study published in the February issue of Cancer Epidemiology, Biomarkers & Prevention.

Findings Released for First Autopsy on Fatal MERS-CoV Case

The main histopathologic findings of Middle East respiratory syndrome coronavirus (MERS-CoV) infection are diffuse alveolar damage in the lungs and evidence of chronic disease in other organs, according to research published online in The American Journal of Pathology.

Does Acetazolamide Reduce Mechanical Ventilation Duration in COPD Patients?

Acetazolamide does not differ from placebo in effect on the duration of invasive mechanical ventilation in patients with chronic obstructive pulmonary disease (COPD)

Featured courses from mycme

Intensive Review of Internal MedicineExternal web site

Enhance your internal medicine knowledge and prepare for your ABIM exam with this ...

CME 77.50 Credits

Genes Offer Clues to Cough CauseExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Comprehensive Review of Family MedicineExternal web site

This comprehensive review covers the full spectrum of topics applicable to Family Medicine ...

CME 57.00 Credits

Sign Up for Free e-newsletters